Drug Trial Radar · NCT07110766
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Aug 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Aug 9, 2025
Primary completion
Sep 15, 2025
Study completion Oct 30, 2025
Sponsor
- Lead sponsor
- MindRank AI LtdIndustry
- Sponsor type
- Industry
- First posted
- Aug 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 12 weeks, multicenter, randomized, double-blind, placebo, parallel-controlled Phase Ib trail comparing the efficacy and safety of MDR-001 tablet versus placebo as an adjunct to a reduced calorie diet and increased physical activity in subjects with overweight or obesity, and to explore the optimal dose selection to support the subsequent Pivotal trial.
Conditions
- Obesity &Amp; Overweight
Interventions
MDR-001Drug
Oral administration of small molecule MDR-001 tablets
PlaceboDrug
Administered orally placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Body Weight From Baseline at Week 12Time frame: Baseline, Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The first hospital of Jilin University
Ch’ang-ch’un, Jilin, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.